Search

Learn how a new kind of CAR T cell therapy could be a major advance for treating acute myeloid leukemia.

… Monday, April 22, 2024 Acute myeloid leukemia (AML) is one of the most challenging blood cancers . The disease moves quickly and needs aggressive treatment with chemotherapy , sometimes followed by a  bone marrow transplant . Even when the first round of therapy works, AML often returns. Now a clinical

Memorial Sloan Kettering Cancer Center (MSK) was recently notified by a third-party software vendor, Accellion, Inc., of a technical vulnerability in a document-sharing system used at MSK. MSK was one of many Accellion customers whose document-sharing systems were involved in this incident. After a full investigation, we discovered that an unauthorized party was able to access and copy a subset of electronic documents stored on the system.

… Wednesday, March 31, 2021 Memorial Sloan Kettering Cancer Center (MSK) was recently notified by a third-party software vendor, Accellion, Inc., of a technical vulnerability in a document-sharing system used at MSK. MSK was one of many Accellion customers whose document-sharing systems were involved in

In recent years, there has been a shift toward capturing information about the side effects caused by new treatments directly from patients.

… Tuesday, February 26, 2019 Summary Patients’ reports on their symptoms and experiences are considered the gold standard for documenting side effects in clinical research. Memorial Sloan Kettering researchers oversee hundreds of clinical trials every year. Some of the most exciting and potentially revolutionary

Join us from 10:00 a.m. to 12:00 p.m. ET for the June 11 session of “MSK Science Spotlight” recognizing this year’s winners of the Tri-Institutional Breakout Prize for Junior Investigators.

… Thursday, June 11, 2020 Join us from 10:00 a.m. to 12:00 p.m. ET for the June 11 session of “ MSK Science Spotlight ” recognizing this year’s winners of the Tri-Institutional Breakout Prize for Junior Investigators – Manu Setty , PhD of the Dana Pe’er Lab at the Sloan Kettering Institute ; Alexander

Two Memorial Sloan Kettering physician-scientists were elected to one of the nation’s oldest and most respected medical honor societies.

… Friday, July 11, 2014 Physician-scientists Viviane Tabar and Lorenz Studer have been elected to the American Society for Clinical Investigation (ASCI) for 2014. The ASCI, one of the nation’s oldest and most respected medical honor societies, is dedicated to the advancement of research that extends our

For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.

… Wednesday, November 25, 2020 Summary For nearly two decades, MSK has led the way in matching people who have lung cancer with the best targeted therapies for their disease. EGFR . ALK . BRAF. MET. NTRK. RET. ROS1. This may seem like what you see when you dump a box of Scrabble tiles on a table, but these

Para que el tratamiento personalizado funcione, es importante analizar el tumor de cada persona en busca de mutaciones genéticas y encontrar los mejores fármacos para atacar esas mutaciones.

… Wednesday, November 25, 2020 Resumen Durante casi dos décadas, MSK ha sido pionero en conectar a las personas con cáncer pulmonar con las mejores terapias dirigidas para su enfermedad. EGFR . ALK . BRAF. MET. NTRK. RET. ROS1. Esto puede parecerse a lo que ve cuando derrama una caja de fichas de Scrabble

An inside look at the research of MSK's Dr. Michael Kharas, whose work on RNA biology is shedding new light on cancer.

… Wednesday, June 5, 2024 “The blueprint of life.” “The genetic code.” The metaphors we used to describe DNA make it sound almost sacred. Proteins, too, are revered. They are the “workhorses of the cell.” They make things happen. RNA, by contrast, has not been so exalted. It is simply “the messenger,”

Read about the research of Renhe Luo, winner of the 2024 GSK Chairman’s Prize, who studies gene enhancers.

… Thursday, August 29, 2024 Renhe Luo, PhD , who recently graduated from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , has been awarded the 2024 Chairman’s Prize. The competitive award is presented annually and was established by  GSK’s Board of Trustees Chair Emeritus Louis

… Friday, September 13, 2024 Alan Ho, MD, PhD , has been named the Chief of the Head and Neck Oncology Service within the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). Dr. Ho currently serves as a Head and Neck Medical Oncologist and a Cellular